ExploreInterventionESRT
Intervention

ESRT

Also known as: ESRT (pooled ESRT-1 + ESRT-2 mindfulness-based cognitive training) for PGY-1 residents
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI
None
improvement

Pooled ESRT participants showed a significant 26-37% relative reduction in activity of three stress-stimulated pro-inflammatory signaling pathways (NF-kB, AP-1, CREB) compared to controls, consistent

Effect: improvement; NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold, p = 0.031; CREB: 0.63-fold, p = 0.048; CI: NF-kB: 95% CI (0.56, 0.99); AP-1

Size: NF-kB: 0.74-fold relative change, p = 0.043; AP-1: 0.73-fold CI: NF-kB: 95% CI (0.56, 0.99); AP-1: 95% CI

Papers (1)